DR.MAX secures contract for Antineoplastic and immunomodulating agents framework agreement for the supply of medicines from the group antineoplastic and immunomodulatory - Pembrolizumab conc pt sol perf 25mg ml -

Romania, April 27 -- Romania based DR.MAX has secured contract from Operator SEAP for Antineoplastic and immunomodulating agents framework agreement for the supply of medicines from the group antineoplastic and immunomodulatory - Pembrolizumab conc pt sol perf 25mg ml -. The value of the contract is worth 2158594000 RON.

Published by HT Digital Content Services with permission from Pivotal Sources....